Subcutaneous semaglutide (NN9535) for the treatment of type 2 diabetes
Year: 2018
Type: review
Institution: University of Maryland, Baltimore
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2792638657
